(Reuters) - The deal must be approved by shareholders of both companies
and federal anti-trust officials.
The acquisition, which would expand Hologic's product and
geographic reach while providing cost-cutting opportunities, is
expected to close in the third calendar quarter.
Read more at Reuters.com Mergers News
and federal anti-trust officials.
The acquisition, which would expand Hologic's product and
geographic reach while providing cost-cutting opportunities, is
expected to close in the third calendar quarter.
Read more at Reuters.com Mergers News
No comments:
Post a Comment